ライフサイエンスコーパス: nebulization

1 -fold enhancement over conventional solution nebulization.

2 nt to materials synthesis are cavitation and nebulization.

3 rded respirable-size aerosol particles after nebulization.

4 Continuous nebulization, addition of magnesium sulfate to SABA, and

5 ing fluid (ELF) and plasma after aerosolized nebulization (AeroEclipse), of amphotericin B lipid comp

6 Forty-eight hours after the last nebulization, airway responsiveness was monitored by the

7 Sheath gas assists in nebulization and a sample splitter reduces the delay tim

8 Cells were aerosolized by nebulization and directly transmitted into the ATOFMS.

9 0.5% to 37.4 +/- 1.6%, with breath-actuated nebulization and humidity identified as the most importa

10 Total genomic DNA was sheared by nebulization, and fragments between 800 and 1,500 bp wer

11 ametric optimization of sample introduction, nebulization, and hollow cathode source conditions is pe

12 ts, due to the thermal treatment inherent to nebulization, and thus avoids salt-adduct formation that

13 either as an intraperitoneal injection or by nebulization before allergen challenge.

14 Prostacyclin nebulization can be used without the highly sophisticate

15 eriments with enzymic proteins revealed that nebulization caused no detectable loss of catalytic acti

16 Therefore, appropriate modifications in the nebulization chamber and in the conventional nebulizer w

17 nificantly higher heart rate after albuterol nebulization compared with the control group.

18 metric optimization for sample introduction, nebulization, desolvation, and hollow cathode source con

19 with an in-house-fabricated high-efficiency nebulization-desolvation system.

20 Employing modern nebulization equipment coupled with serologic, cell cult

21 jects received three doses of 2.5 mg each by nebulization every 20 min.

22 bles affecting the extraction yield were the nebulization gas flow rate, liquid flow rate, extraction

23 n group, or d) 40 mg of albuterol continuous nebulization group (n=5 animals per group).

24 cated to a) sham group, b) saline continuous nebulization group, c) 20 mg of albuterol continuous neb

25 tion group, c) 20 mg of albuterol continuous nebulization group, or d) 40 mg of albuterol continuous

26 ffects traditionally encountered in solution nebulization ICPMS.

27 nflammatory effects, is given via continuous nebulization in children with severe asthma.

28 tributions for indirect and direct pneumatic nebulizations in plasma spectrometry.

29 Prostacyclin nebulization is an excellent tool to reduce pulmonary hy

30 Here we show that via liquid nebulization (LN) with online, high-flow-rate dilution (

31 impaction, followed by analysis by solution nebulization MC-ICP-MS, as well as imaging using electro

32 HELIOX or AIR as the driving gas for updraft nebulization of a mixture of albuterol 2.5 mg and ipratr

33 Continuous nebulization of albuterol improves pulmonary function vi

34 lude that administration through aerosolized nebulization of amphotericin B lipid complex every 24 hr

35 e of HELIOX as a driving gas for the updraft nebulization of bronchodilators during the first 2 hrs o

36 mass concentrations generated by ultrasonic nebulization of deionized (DI) water stored in a variety

37 s 0 and 7, and challenged by inhalation with nebulization of either OVA or saline.

38 Nebulization of epinephrine reduces airway blood flow an

39 Nebulization of epinephrine significantly reduced trache

40 Moreover, nebulization of NSC23766 decreased eosinophil and neutro

41 n SMCs or pharmacological Rac1 inhibition by nebulization of NSC23766 prevented AHR in murine models

42 the clinical potential of CXCR7 antagonism, nebulization of the agent before and after the inflammat

43 ly technique has been developed that entails nebulization of the compound dissolved in ethanol and su

44 aerosol-phase extraction (APE), is based on nebulization of the extracting aqueous solution (0.1 mol

45 Desolvation and nebulization of the samples were supported by a heated r

46 er inhalation injury and identifies low-dose nebulization of tiotropium bromide as a potentially effi

47 mospheric pressure (a process referred to as nebulization or atomization).

48 direct nanoparticle (NP) introduction using nebulization or microdroplet generation systems.

49 The nebulization process was identified as the most critical

50 ivery of nitrite dissolved in saline through nebulization produced selective, sustained pulmonary vas

51 mide 1 hr before injury (n=6) and postinjury nebulization protocols of 18 mug (n=6), 36 mug (n=6), an

52 ups, including both preinjury and postinjury nebulization protocols.

53 S for a range of mineral waters by pneumatic nebulization sample introduction and the analysis of gen

54 metry (MS) detection, demonstrating that SAW nebulization (SAWN) can be performed either in a discont

55 Surface acoustic wave nebulization (SAWN) is a new technique that has been dem

56 Surface acoustic wave nebulization (SAWN) is a novel method to transfer nonvol

57 nd the sample introduction efficiency of the nebulization system.

58 Two major findings are realized for three nebulization systems: (1) a direct injection high-effici

59 report the optimization and use of SAWN as a nebulization technique for the introduction of samples f

60 ory group compared 6 protocols: 4 followed a nebulization technique using hypertonic saline, and 2 fo

61 PERCH selected the nebulization technique using hypertonic saline.

62 Nebulization (the creation of mist from ultrasound passi

63 To examine whether HS nebulization treatment would decrease the hospital admis

64 Two 20-minute nebulization treatments of 4 mL of HS, 3%, or 4 mL of no

65 Treatments for these groups included nebulization with 36 mug of tiotropium bromide 1 hr befo

66 ated with the TLR2 agonist Pam3CSK4 prior to nebulization with the neutrophil chemotactic agent LTB4.

67 d that albuterol administered via continuous nebulization would mitigate acute lung injury after smok